United States (USA) Orthopedic Devices Market Size (Value, Volume, ASP) by Segments (Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction and Others), Share and Forecast, 2015-2025
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Published: February 26, 2021 Report Code: GDMEMC0619DB-ST
- Share on Twitter
- Share on LinkedIn
- Share on Facebook
- Share on Threads
- Share via Email
- Copy Link
GlobalData’s “United States Orthopedic Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Orthopedic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools and Consumables, Other Joint Reconstruction, Shoulder Replacement, Spinal Surgery and Trauma Fixation.
The United States Orthopedic Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Orthopedic Devices Market.
• Global corporate-level profiles of key companies operating within the United States Orthopedic Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Orthopedic Devices is segmented as follows:
• Arthroscopy
• Cranio Maxillofacial Fixation (CMF)
• Hip Reconstruction
• Knee Reconstruction
• Orthobiologics
• Orthopedic Bone Cement and Casting Materials
• Orthopedic Power Tools and Consumables
• Other Joint Reconstruction
• Shoulder Replacement
• Spinal Surgery
• Trauma Fixation
Reasons to Buy
Key Reasons to Purchase – The United States Orthopedic Devices Market report helps you to develop:
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
• Stryker Corp
• DePuy Synthes Inc
• Zimmer Biomet Holdings Inc
Table of Contents
1 Table of Contents
|1 Table of Contents 3
|1.1 List of Tables 14
|1.2 List of Figures 21
2 Introduction 24
2.1 What Is This Report About? 24
2.2 Orthopedic Devices Market Segmentation 24
2.3 Definitions of Markets Covered in the Report 27
3 Orthopedic Devices Market, United States 46
3.1 Orthopedic Devices Market, United States, Revenue ($m), 2015-2025 46
3.2 Orthopedic Devices Market, United States, Revenue Mix ($m), 2019 48
3.3 Orthopedic Devices Market, United States, Category Contribution by Revenue ($m), 2019 49
3.4 Orthopedic Devices Market, United States, Revenue ($m), 2015-2025 51
3.5 Orthopedic Devices Market, United States, Volume (Units), 2015-2025 54
3.6 Orthopedic Devices Market, United States, Volume (Units), 2015-2025 56
3.7 Orthopedic Devices Market, United States, Company Share by Revenue ($m), 2019 59
4 Arthroscopy Market, United States 61
4.1 Arthroscopy Market, United States, Revenue Mix ($m), 2019 61
4.2 Arthroscopy Market, United States, Segment Contribution (%), 2019 62
4.3 Arthroscopy Market, United States, Revenue ($m), 2015-2025 63
4.3.1 Arthroscopes and Arthroscopic Systems Market, United States, Revenue ($m), by Segment, 2015-2025 66
4.3.2 Arthroscopic Shavers Market, United States, Revenue ($m), by Segment, 2015-2025 68
4.3.3 Arthroscopy Implants Market, United States, Revenue ($m), by Segment, 2015-2025 70
4.3.4 Arthroscopy Radio Frequency Systems and Wands Market, United States, Revenue ($m), by Segment, 2015-2025 72
4.4 Arthroscopy Market, United States, Volume (Units), 2015-2025 74
4.4.1 Arthroscopes and Arthroscopic Systems Market, United States, Volume (Units), by Segment, 2015-2025 76
4.4.2 Arthroscopic Shavers Market, United States, Volume (Units), by Segment, 2015-2025 78
4.4.3 Arthroscopy Implants Market, United States, Volume (Units), by Segment, 2015-2025 80
4.4.4 Arthroscopy Radio Frequency Systems and Wands Market, United States, Volume (Units), by Segment, 2015-2025 82
4.5 Arthroscopy Market, United States, Average Price ($), 2015-2025 84
4.6 Arthroscopy Market, United States, Distribution Share by Revenue ($m), 2019 86
4.7 Arthroscopy Market, United States, Company Share by Revenue ($m), 2019 87
5 Cranio Maxillofacial Fixation (CMF) Market, United States 89
5.1 Cranio Maxillofacial Fixation (CMF) Market, United States, Revenue Mix ($m), 2019 89
5.2 Cranio Maxillofacial Fixation (CMF) Market, United States, Segment Contribution (%), 2019 90
5.3 Cranio Maxillofacial Fixation (CMF) Market, United States, Revenue ($m), 2015-2025 91
5.3.1 Distraction Systems Market, United States, Revenue ($m), by Segment, 2015-2025 93
5.3.2 Plate and Screw Fixators Market, United States, Revenue ($m), by Segment, 2015-2025 95
5.4 Cranio Maxillofacial Fixation (CMF) Market, United States, Volume (Units), 2015-2025 97
5.4.1 Distraction Systems Market, United States, Volume (Units), by Segment, 2015-2025 99
5.4.2 Plate and Screw Fixators Market, United States, Volume (Units), by Segment, 2015-2025 101
5.5 Cranio Maxillofacial Fixation (CMF) Market, United States, Average Price ($) , 2015-2025 103
5.6 Cranio Maxillofacial Fixation (CMF) Market, United States, Distribution Share by Revenue ($m), 2019 104
5.7 Cranio Maxillofacial Fixation (CMF) Market, United States, Company Share by Revenue ($m), 2019 105
6 Hip Reconstruction Market, United States 107
6.1 Hip Reconstruction Market, United States, Revenue Mix ($m), 2019 107
6.2 Hip Reconstruction Market, United States, Segment Contribution (%), 2019 108
6.3 Hip Reconstruction Market, United States, Revenue ($m), 2015-2025 109
6.3.1 Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 111
6.3.2 Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 113
6.4 Hip Reconstruction Market, United States, Volume (Units), 2015-2025 115
6.4.1 Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025 117
6.4.2 Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025 119
6.5 Hip Reconstruction Market, United States, Average Price ($) , 2015-2025 121
6.6 Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), 2019 123
6.7 Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2019 124
7 Knee Reconstruction Market, United States 126
7.1 Knee Reconstruction Market, United States, Revenue Mix ($m), 2019 126
7.2 Knee Reconstruction Market, United States, Segment Contribution (%), 2019 127
7.3 Knee Reconstruction Market, United States, Revenue ($m), 2015-2025 128
7.3.1 Partial Knee Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 130
7.3.2 Primary Knee Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 132
7.4 Knee Reconstruction Market, United States, Volume (Units), 2015-2025 134
7.4.1 Partial Knee Replacement Market, United States, Volume (Units), by Segment, 2015-2025 136
7.4.2 Primary Knee Replacement Market, United States, Volume (Units), by Segment, 2015-2025 138
7.5 Knee Reconstruction Market, United States, Average Price ($) , 2015-2025 140
7.6 Knee Reconstruction Market, United States, Distribution Share by Revenue ($m), 2019 142
7.7 Knee Reconstruction Market, United States, Company Share by Revenue ($m), 2019 143
8 Orthobiologics Market, United States 145
8.1 Orthobiologics Market, United States, Revenue Mix ($m), 2019 145
8.2 Orthobiologics Market, United States, Segment Contribution (%), 2019 146
8.3 Orthobiologics Market, United States, Revenue ($m), 2015-2025 147
8.3.1 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 150
8.3.2 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2015-2025 153
8.3.3 Cartilage Repair Market, United States, Revenue ($m), by Segment, 2015-2025 155
8.3.4 Soft Tissue Biologics Market, United States, Revenue ($m), by Segment, 2015-2025 157
8.3.5 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2015-2025 159
8.4 Orthobiologics Market, United States, Volume (Units), 2015-2025 161
8.4.1 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 164
8.4.2 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2015-2025 167
8.4.3 Cartilage Repair Market, United States, Volume (Units), by Segment, 2015-2025 169
8.4.4 Soft Tissue Biologics Market, United States, Volume (Units), by Segment, 2015-2025 171
8.4.5 Viscosupplementation Market, United States, Volume (Units), by Segment, 2015-2025 173
8.5 Orthobiologics Market, United States, Average Price ($) , 2015-2025 175
8.6 Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2019 179
8.7 Orthobiologics Market, United States, Company Share by Revenue ($m), 2019 180
9 Orthopedic Bone Cement and Casting Materials Market, United States 182
9.1 Orthopedic Bone Cement and Casting Materials Market, United States, Revenue Mix ($m), 2019 182
9.2 Orthopedic Bone Cement and Casting Materials Market, United States, Segment Contribution (%), 2019 183
9.3 Orthopedic Bone Cement and Casting Materials Market, United States, Revenue ($m), 2015-2025 184
9.3.1 Bone Cement Market, United States, Revenue ($m), by Segment, 2015-2025 186
9.3.2 Casting Materials Market, United States, Revenue ($m), by Segment, 2015-2025 188
9.4 Orthopedic Bone Cement and Casting Materials Market, United States, Volume (Units), 2015-2025 190
9.4.1 Bone Cement Market, United States, Volume (Units), by Segment, 2015-2025 192
9.4.2 Casting Materials Market, United States, Volume (Units), by Segment, 2015-2025 194
9.5 Orthopedic Bone Cement and Casting Materials Market, United States, Average Price ($), 2015-2025 196
9.6 Orthopedic Bone Cement and Casting Materials Market, United States, Distribution Share by Revenue ($m), 2019 197
9.7 Orthopedic Bone Cement and Casting Materials Market, United States, Company Share by Revenue ($m), 2019 198
10 Orthopedic Power Tools and Consumables Market, United States 200
10.1 Orthopedic Power Tools and Consumables Market, United States, Revenue Mix ($m), 2019 200
10.2 Orthopedic Power Tools and Consumables Market, United States, Segment Contribution (%), 2019 201
10.3 Orthopedic Power Tools and Consumables Market, United States, Revenue ($m), 2015-2025 202
10.3.1 Consumables Market, United States, Revenue ($m), by Segment, 2015-2025 204
10.3.2 Power Tools Market, United States, Revenue ($m), by Segment, 2015-2025 206
10.4 Orthopedic Power Tools and Consumables Market, United States, Volume (Units), 2015-2025 208
10.4.1 Consumables Market, United States, Volume (Units), by Segment, 2015-2025 210
10.4.2 Power Tools Market, United States, Volume (Units), by Segment, 2015-2025 212
10.5 Orthopedic Power Tools and Consumables Market, United States, Average Price ($), 2015-2025 214
10.6 Orthopedic Power Tools and Consumables Market, United States, Distribution Share by Revenue ($m), 2019 216
10.7 Orthopedic Power Tools and Consumables Market, United States, Company Share by Revenue ($m), 2019 217
11 Other Joint Reconstruction Market, United States 219
11.1 Other Joint Reconstruction Market, United States, Revenue Mix ($m), 2019 219
11.2 Other Joint Reconstruction Market, United States, Segment Contribution (%), 2019 220
11.3 Other Joint Reconstruction Market, United States, Revenue ($m), 2015-2025 221
11.3.1 Ankle Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 224
11.3.2 Digits Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 226
11.3.3 Elbow Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 228
11.3.4 Wrist Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 230
11.4 Other Joint Reconstruction Market, United States, Volume (Units), 2015-2025 232
11.4.1 Ankle Replacement Market, United States, Volume (Units), by Segment, 2015-2025 235
11.4.2 Digits Replacement Market, United States, Volume (Units), by Segment, 2015-2025 237
11.4.3 Elbow Replacement Market, United States, Volume (Units), by Segment, 2015-2025 239
11.4.4 Wrist Replacement Market, United States, Volume (Units), by Segment, 2015-2025 241
11.5 Other Joint Reconstruction Market, United States, Average Price ($), 2015-2025 243
11.6 Other Joint Reconstruction Market, United States, Distribution Share by Revenue ($m), 2019 245
11.7 Other Joint Reconstruction Market, United States, Company Share by Revenue ($m), 2019 246
12 Shoulder Replacement Market, United States 248
12.1 Shoulder Replacement Market, United States, Revenue Mix ($m), 2019 248
12.2 Shoulder Replacement Market, United States, Segment Contribution (%), 2019 249
12.3 Shoulder Replacement Market, United States, Revenue ($m), 2015-2025 250
12.4 Shoulder Replacement Market, United States, Volume (Units), 2015-2025 253
12.5 Shoulder Replacement Market, United States, Average Price ($) , 2015-2025 256
12.6 Shoulder Replacement Market, United States, Distribution Share by Revenue ($m), 2019 257
12.7 Shoulder Replacement Market, United States, Company Share by Revenue ($m), 2019 258
13 Spinal Surgery Market, United States 260
13.1 Spinal Surgery Market, United States, Revenue Mix ($m), 2019 260
13.2 Spinal Surgery Market, United States, Segment Contribution (%), 2019 261
13.3 Spinal Surgery Market, United States, Revenue ($m), 2015-2025 262
13.3.1 Minimal Invasive Spinal Devices Market, United States, Revenue ($m), by Segment, 2015-2025 265
13.3.2 Spinal Fusion Market, United States, Revenue ($m), by Segment, 2015-2025 267
13.3.3 Spinal Non-Fusion Market, United States, Revenue ($m), by Segment, 2015-2025 269
13.3.4 Vertebral Body Replacement Systems Market, United States, Revenue ($m), by Segment, 2015-2025 272
13.3.5 Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), by Segment, 2015-2025 274
13.4 Spinal Surgery Market, United States, Volume (Units), 2015-2025 276
13.4.1 Minimal Invasive Spinal Devices Market, United States, Volume (Units), by Segment, 2015-2025 279
13.4.2 Spinal Fusion Market, United States, Volume (Units), by Segment, 2015-2025 281
13.4.3 Spinal Non-Fusion Market, United States, Volume (Units), by Segment, 2015-2025 283
13.4.4 Vertebral Body Replacement Systems Market, United States, Volume (Units), by Segment, 2015-2025 286
13.4.5 Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), by Segment, 2015-2025 288
13.5 Spinal Surgery Market, United States, Average Price ($) , 2015-2025 290
13.6 Spinal Surgery Market, United States, Distribution Share by Revenue ($m), 2019 294
13.7 Spinal Surgery Market, United States, Company Share by Revenue ($m), 2019 295
14 Trauma Fixation Market, United States 297
14.1 Trauma Fixation Market, United States, Revenue Mix ($m), 2019 297
14.2 Trauma Fixation Market, United States, Segment Contribution (%), 2019 298
14.3 Trauma Fixation Market, United States, Revenue ($m), 2015-2025 299
14.3.1 External Fixators Market, United States, Revenue ($m), by Segment, 2015-2025 301
14.3.2 Internal Fixators Market, United States, Revenue ($m), by Segment, 2015-2025 303
14.4 Trauma Fixation Market, United States, Volume (Units), 2015-2025 306
14.4.1 External Fixators Market, United States, Volume (Units), by Segment, 2015-2025 308
14.4.2 Internal Fixators Market, United States, Volume (Units), by Segment, 2015-2025 310
14.5 Trauma Fixation Market, United States, Average Price ($), 2015-2025 313
14.6 Trauma Fixation Market, United States, Distribution Share by Revenue ($m), 2019 315
14.7 Trauma Fixation Market, United States, Company Share by Revenue ($m), 2019 316
15 Overview of Key Companies in United States, Orthopedic Devices Market 317
15.1 Stryker Corp 317
15.1.1 Company Overview 317
15.2 DePuy Synthes Inc 317
15.2.1 Company Overview 317
15.3 Zimmer Biomet Holdings Inc 317
15.3.1 Company Overview 317
15.4 Medtronic Plc 318
15.4.1 Company Overview 318
15.5 Wright Medical Group NV 318
15.5.1 Company Overview 318
15.6 Arthrex Inc 318
15.6.1 Company Overview 318
15.7 Smith & Nephew Plc 318
15.7.1 Company Overview 318
15.8 NuVasive Inc 319
15.8.1 Company Overview 319
15.9 Globus Medical Inc 319
15.9.1 Company Overview 319
16 Orthopedic Devices Market Pipeline Products 320
17 Financial Deals Landscape 324
17.1 Acquisition 324
17.1.1 DJO Acquires Trilliant Surgical 324
17.1.2 ARCH Global Precision Acquires LISI Medical Jeropa 325
17.1.3 STERIS to Acquire Cantel Medical 326
17.1.4 Stryker Acquires OrthoSensor 328
17.1.5 Curiteva Acquires FossiLabs 329
17.1.6 Integra LifeSciences Acquires ACell 330
17.1.7 Motion Dynamics Acquires ViaMed 332
17.1.8 Pharmaron Acquires Absorption Systems 333
17.1.9 Surgalign Holdings Acquires Holo Surgical 335
17.1.10 WishBone Medical Acquires Back 2 Basics and Orbbo Surgical 337
17.1.11 Vilex Acquires DT MedTech 338
17.1.12 Spineart to Acquire Meditech Spine 339
17.1.13 Nordson Acquires Fluortek 340
17.1.14 Pantheon Spinal Acquires Incite Innovation 341
17.1.15 Aspen Surgical Acquires Precept Medical Products 342
17.1.16 Conventus Orthopaedics Acquires Flower Orthopedics 343
17.1.17 Nextremity Solutions to Acquire Lakeland Technology 344
17.1.18 Conatus Pharma Acquires Histogen 345
17.1.19 Halma Acquires NovaBone Products 347
17.2 Asset Transactions 348
17.2.1 Spinal Elements Acquires Assets of Benvenue Medical 348
17.2.2 DJO Acquires STAR Ankle and Finger Arthroplasty Systems from Stryker 349
17.2.3 Proteor USA to Acquire Freedom Innovations Assets from Ottobock 350
17.2.4 Smith+Nephew Acquires Extremity Orthopaedics Business from Integra LifeSciences 351
17.2.5 Pantheon Surgical Acquires Blue Topaz/CompresSIve Technology from Osseus Fusion Systems 353
17.2.6 Steeper Acquires Espire Elbow Prostheses Range from College Park Industries 354
17.3 Debt Offerings 355
17.3.1 Stryker Prices USD600 Million in Public Offering of
0.600% Senior Notes Due 2023 355
17.3.2 Baxter International to Raise USD650 Million in Private Placement of Notes Due 2031 356
17.3.3 Johnson & Johnson Raises USD1 Billion in Public Offering of
0.550% Notes Due 2025 357
17.3.4 Johnson & Johnson Raises USD1.5 Billion in Public Offering of
0.950% Notes Due 2027 359
17.3.5 Johnson & Johnson Raises USD1.75 Billion in Public Offering of
1.300% Notes Due 2030 361
17.3.6 Johnson & Johnson Raises USD1 Billion in Public Offering of
2.100% Notes Due 2040 363
17.3.7 Johnson & Johnson Raises USD1 Billion in Public Offering of
2.250% Notes Due 2050 365
17.3.8 Johnson & Johnson Raises USD1.25 Billion in Public Offering of
2.450% Notes Due 2060 367
17.3.9 CryoLife Prices Private Placement of
4.250% Notes Due 2025 for USD100 Million 369
17.3.10 NuVasive Raises USD450 Million in Private Placement of 1% Convertible Senior Notes Due 2023 371
17.3.11 Stryker Raises USD650 Million in Public Offering of
1.15% Notes Due 2025 373
17.3.12 Stryker Raises USD1 Billion in Public Offering of
1.95% Notes Due 2030 375
17.3.13 Stryker Raises USD650 Million in Public Offering of
2.9% Notes Due 2050 377
17.3.14 Teleflex Prices Private Placement of
4.25% Notes Due 2028 for USD500 Million 379
17.3.15 Cantel Medical Raises USD168 Million in Private Placement of
3.25% Notes Due 2025 380
17.3.16 Nevro Announces Full Exercise of Underwriter’s Option to Purchase Additional
2.75% Notes Due 2025 for USD189.8 Million 382
17.3.17 Baxter International Raises USD500 Million in Private Placement of
3.95% Senior Notes Due 2030 384
17.3.18 Baxter International Raises USD750 Million in Private Placement of
3.75% Senior Notes Due 2025 385
17.3.19 Zimmer Biomet Prices Public Offering of
3.55% Notes Due 2030 for USD900 Million 386
17.3.20 Zimmer Biomet Prices Public Offering of
3.05% Notes Due 2026 for USD600 Million 388
17.3.21 NuVasive Prices Private Placement of
0.375% Notes Due 2025 for USD450 Million 390
17.3.22 Integra LifeSciences Prices Private Placement of
0.5% Convertible Senior Notes Due 2025 for USD500 Million 392
17.4 Equity Offerings 394
17.4.1 Pro-Dex Plans to Raise up to USD25 million in Public Offering of Shares 394
17.4.2 Histogen Raises USD14 Million in Public Offering of Shares 396
17.4.3 PRO-Dex Plans to Raise up to USD100 Million in Public Offering 398
17.4.4 Histogen Raises USD4.5 Million in Private Placement of Shares 400
17.4.5 InVivo Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants 401
17.4.6 SI-Bone Raises USD76.5 Million in Public Offering of Shares 403
17.4.7 Alphatec Holdings Raises USD115 Million in Public Offering of Shares 405
17.4.8 Spinal Elements to Raise up to USD115.5 Million in IPO of Shares 407
17.4.9 Aziyo Biologics Prices IPO of Shares for USD50 Million 409
17.4.10 SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities 410
17.4.11 ConforMIS Prices Private Placement of Units for USD17.2 Million 411
17.4.12 CryoLife Raises USD20 Million in Equity Financing 413
17.4.13 Histogen Files Registration Statement for Public Offering of Securities for up to USD125 Million 414
17.4.14 Ocugen Plans to Raise up to USD30 Million in Public Offering of Shares 415
17.4.15 Xtant Medical to Raise up to USD15 Million in Rights Offering of Shares 417
17.4.16 ConforMIS Plans to Raise up to USD25 Million in Public Offering of Shares 418
17.4.17 SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares 419
17.4.18 SINTX Technologies Prices Private Placement of Shares for USD3 Million 421
17.4.19 ACell to Raise up to USD80 Million in IPO of Shares 422
17.4.20 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 424
17.4.21 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 426
17.4.22 OrthoPediatrics Raises USD75.2 Million in Public Offering of Shares 427
17.4.23 NFL Players Invests in TendoNova 429
17.4.24 SurModics Plans to Raise up to USD200 Millon in Public Offering of Securities 430
17.4.25 Hackensack Meridian Health Invests in EpiBone 431
17.4.26 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD75 Million 432
17.4.27 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD25 Million 434
17.4.28 InVivo Therapeutics Raises USD3 Million in Private Placement of Shares 436
17.4.29 Nevro Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares for USD157 Million 437
17.4.30 Healios Invests Additional USD7 Million in Athersys 439
17.4.31 Conformis Files Registration Statement for Public Offering of Securities up to USD200 Million 440
17.4.32 InVivo Therapeutics Raises USD7 Million in Public Offering of Shares and Warrants 442
17.4.33 CartiHeal May Raise up to USD80 Million in IPO of Shares 444
17.4.34 DiscGenics to Raise Funds through Private Placement 445
17.4.35 Myomo Raises USD15 Million in Public Offering of Shares 446
17.4.36 Aurora Spine Raises USD0.2 Million in Equity Offering 448
17.4.37 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 449
17.5 Grants 450
17.5.1 User-driven Retrospectively Supervised Classification Updating (RESCU) system for robust upper limb prosthesis control 450
17.5.2 Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants 451
17.5.3 Novel Test of Infant Hearing 452
17.5.4 Performance Evaluation of a non-Degradable Synthetic Device for Chondral and Osteochondral Defects of the Knee 453
17.5.5 Powered Hand Grip Orthosis for Functional Independence 454
17.5.6 Multifunctional Semi-Powered Ankle Prosthesis: Phase II 455
17.5.7 Noninvasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss 456
17.5.8 Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants 457
17.5.9 Div. Supplement: Performance Evaluation of a non-Degradable Synthetic Device for Chondral and Osteochondral Defects of the Knee 458
17.5.10 IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy 459
17.5.11 User-driven Retrospectively Supervised Classification Updating (RESCU) system for robust upper limb prosthesis control 460
17.5.12 Ultra-low Fouling and Nitric Oxide Releasing Intravascular Catheters for Prevention of Thrombosis and Infection 461
17.6 Merger 462
17.6.1 Acumed Merges with OsteoMed 462
17.7 Partnerships 463
17.7.1 Revive Therapeutics Enters into Research Collaboration with North Carolina State University 463
17.7.2 Ortho Regenerative Enters into Licensing Agreement with Hanuman Pelican 464
17.7.3 Center for Computational Imaging and Personalized Diagnostic (CCIPD) Enters into Research Agreement with Boehringer Ingelheim 465
17.7.4 icotec Enters into Distribution Agreement with G21 466
17.7.5 Exactech and Bodycad Enter into Distribution Agreement 467
17.7.6 In2Bones USA and Invibio Enter into R&D, Development and Manufacturing Agreement 468
17.7.7 QIAGEN Enters into Research License and Option Agreement with TScan Therapeutics to Develop T Cell-Based Lab Test for COVID-19 Immune Response 469
17.7.8 Penumbra Enters into Partnership with RapidAI 470
17.7.9 OPUM Enters into Agreement with iProcedures 471
17.7.10 Orthofix Medical and Neo Medical Enter into Partnership 472
17.8 Private Equity 473
17.8.1 Alphatec to Raise USD138 Million in Private Placement of Common Stock 473
17.8.2 Umbra Companies to Acquire Ossifix Technologies 475
17.8.3 LKCM Headwater Investments Invests USD20 Million in WishBone Medical 476
17.8.4 Hyperice Raises Funds through Equity Financing 477
17.8.5 ASP Navigate Acquires Life Sciences Unit from NN 479
17.8.6 Histogen to Raise USD10 Million in Private Placement of Shares 481
17.8.7 MiMedx to Raise USD100 Million in Private Equity Financing 483
17.8.8 Fidelio Capital Acquires Majority Stake in Veterinary Orthopedic Implants 485
17.8.9 HealthpointCapital Acquires Majority Stake in IlluminOss Medical 486
17.8.10 York Special Opportunities Fund III Acquires Dr.’s Own (The Good Feet Store) 487
17.8.11 Decathlon Capital Partners Invests in Cirtec Medical 488
17.8.12 Lattice Biologics to Raise USD4.24 Million in Private Placement of Shares 489
17.8.13 Fidelio Capital Acquires BioMedtrix 490
17.9 Venture Financing 491
17.9.1 Octave Bioscience Raises USD32 Million in Series B Financing 491
17.9.2 Carlsmed Raises USD10 Million in Series A Financing 493
17.9.3 Bio2 Technologies Raises USD3.2 Million in Venture Financing 494
17.9.4 Curiteva Raises USD20 Million in Series A Funding Round 495
17.9.5 CoNextions Medical Secures USD2.32 Million in Venture Funding 496
17.9.6 Shoulder Innovations Raises USD21.6 Million in Venture Financing 497
17.9.7 MBio Diagnostics (LightDeck Diagnostics) Raises USD11 Million in Series B Financing 499
17.9.8 ReGelTec Raises USD3.75 Million in Venture Funding 500
17.9.9 Cocoon Biotech Raises USD0.86 Million in Venture Financing 501
17.9.10 Carmell Therapeutics Raises Additional USD2.3 Million in Venture Financing 502
17.9.11 Parvizi Surgical Innovations Invests in Coracoid Solutions 503
17.9.12 DiscGenics Raises USD4 Million in Series A Financing 504
17.9.13 OrthAlign Raises USD11.2 Million in Venture Financing 505
17.9.14 DiscGenics Raises USD50 Million in Series C Financing 506
17.9.15 Active Life Scientific Raises USD1 Million in Venture Financing 508
17.9.16 Paragon 28 Raises Funds through Series B Financing 509
17.9.17 Ben Franklin Technology Partners Invests in Aevumed 510
17.9.18 NuShores Biosciences Raises USD0.3 Million in Venture Financing 511
17.9.19 CurvaFix Raises USD10.8 Million in Series B Financing 512
17.9.20 Spine Align Raises USD1.7 Million in Seed Financing 513
17.9.21 CurvaFix Raises USD3.08 Million in Venture Financing 514
17.9.22 KAHTNU Surgical Raises USD2.2 Million in Series A Financing 515
17.9.23 Ulcer Solutions to Raise USD0.65 Million in Venture Financing 516
17.9.24 Carlsmed Raises USD2.5 Million in Seed Financing 517
17.9.25 GRD Biomechanics Secures USD0.1 Million in Seed Funding 518
17.9.26 HAPPE Spine Raises USD0.3 Million in Financing Round 519
17.9.27 Solenic Medical Raises USD0.1 Million in Venture Financing 520
17.9.28 Conventus Orthopaedics Raises USD24.5 Million in Venture Financing 521
17.9.29 Onkos Surgical Raises USD7.6 Million in Venture Financing 522
17.9.30 Precision Optics Raises USD0.3 Million in Venture Financing 523
17.9.31 Centinel Spine Raises USD40.5 Million in Venture Financing 524
17.9.32 Embody Raises USD9.2 Million in Series A Financing 525
17.9.33 b-ONE Ortho Raises USD14 Million in Venture Financing 526
17.9.34 Therapeutic Articulations Raises Funds through Venture Financing 528
17.9.35 Vivorte Raises USD1 Million in Venture Financing 529
17.9.36 Restor3d Raises Additional USD0.55 Million in Venture Financing 530
17.9.37 TendoNova Raises Additional USD0.1 Million in Venture Financing 531
17.9.38 Nanovis Raises USD5.4 Million in Venture Financing 532
17.9.39 Apos Medical (Apos Therapy) Raises Additional USD11 Million in Series A Financing 533
17.9.40 CyMedica Orthopedics Raises USD2 Million in Venture Financing 534
17.9.41 Integrity Implants Raises USD0.8 Million in Venture Financing 535
17.9.42 Therapeutic Articulations Raises Funds through Financing Round 536
17.9.43 Shoulder Innovations Raises USD2.2 Million in Venture Financing 537
18 Recent Developments 538
18.1 Corporate Communications 538
18.1.1 Jan 13, 2021: MTF Biologics awards over $1 Million in 2020 Extramural Research Grants and announces timeline for 2021 applications 538
18.1.2 Jul 28, 2020: MiMedx adds Rohit Kashyap, Ph.D., to leadership team as Executive Vice President and Chief Commercial Officer 539
18.1.3 May 21, 2020: Prestigious Klee Family Foundation Prize 2020 awarded for outstanding scientific work identifying patient-specific approach as Better Way to optimize knee implant design 539
18.1.4 May 14, 2020: Aesculap wins iF DESIGN AWARD 540
18.1.5 Apr 14, 2020: ValueHealth announces M. Scott Martin, Esq. as Southwest regional president 540
18.1.6 Mar 05, 2020: Ovid Therapeutics announces presentations on OV935/TAK935 (soticlestat) at the American Academy of Neurology 2020 Annual Meeting 541
18.1.7 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference 541
18.1.8 Mar 03, 2020: PDCline Pharma announces the administration of a first patient with its therapeutic cancer vaccine candidate (PDClung01) targeting non-small cell lung cancer 543
18.1.9 Mar 02, 2020: Stryker announces new Investor Relations leader 543
18.1.10 Feb 27, 2020: Cantel appoints Seth Yellin to Chief Growth Officer 544
18.1.11 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum 544
18.1.12 Feb 18, 2020: NN appoints Warren Veltman as president and CEO 544
18.1.13 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement 545
18.1.14 Feb 10, 2020: Roche’s gantenerumab fails in Phase II/III inherited Alzheimer’s trial 545
18.1.15 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan 546
18.1.16 Feb 05, 2020: Conformis appoints Bob Howe as Chief Financial Officer 546
18.1.17 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors 547
18.1.18 Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs 548
18.1.19 Jan 25, 2020: Siemens Healthineers India launches ACUSON Redwood Ultrasound System at IRIA 2020 548
18.2 Financial Announcements 549
18.2.1 Aug 13, 2020: Renishaw: Preliminary announcement of unaudited results for the year ended 30 June 2020 549
18.2.2 Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 552
18.2.3 Mar 12, 2020: Myomo reports 2019 fourth quarter and full year financial results featuring record revenue and gross margins 555
18.2.4 Mar 10, 2020: Electromed launches SmartVest connect mobile application 557
18.2.5 Mar 05, 2020: Cantel Medical reports financial results for its second quarter fiscal year 2020 558
18.2.6 Feb 28, 2020: Lattice Biologics reports Q1 2020 results 558
18.2.7 Feb 20, 2020: LX Analyzer successfully detects Coronavirus RNA 559
18.2.8 Feb 20, 2020: Teleflex reports fourth quarter and full year 2019 results; provides 2020 guidance 561
18.2.9 Feb 20, 2020: Integer Holdings reports results for fourth quarter and full year 2019 562
18.2.10 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance 563
18.2.11 Feb 13, 2020: Precision Optics reports second quarter fiscal year 2020 financial results 564
18.2.12 Feb 13, 2020: CryoLife reports fourth quarter and full year 2019 financial results 565
18.2.13 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020 566
18.2.14 Feb 06, 2020: Myomo reports preliminary fourth quarter and full year 2019 results 566
18.2.15 Feb 06, 2020: Pro-Dex announces fiscal 2020 second quarter and six-month results 567
18.2.16 Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results 567
18.2.17 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results 568
18.2.18 Jan 29, 2020: Current Health collaborates with Mass General Hospital to reduce maternal mortality rates in Sub-Saharan Africa 569
18.2.19 Jan 28, 2020: Beckman Coulter’s Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance 570
18.2.20 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook 571
18.3 Government and Public Interest 572
18.3.1 Nov 18, 2020: OnPoint Surgical to participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum 572
18.3.2 Aug 27, 2020: SANUWAVE Health to Participate in Upcoming September Investor Conferences 572
18.3.3 Jun 30, 2020: HSS study identifies RA patients with worse outcomes after hip or knee replacement 573
18.4 Legal And Regulatory 574
18.4.1 Sep 21, 2020: Orthopedic Clinic pays $1.5 million to settle systemic noncompliance with HIPAA rules 574
18.4.2 Jun 29, 2020: Ozop Surgical completes merger, announces new name 574
18.4.3 Apr 06, 2020: New Jersey Chiropractor agrees to pay $2 million to resolve allegations of unnecessary knee injections and knee braces and related kickbacks 574
18.4.4 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures 575
18.4.5 Mar 05, 2020: U.S. Attorney sues spinal device company and its executives for allegations that they paid kickbacks to surgeons 575
18.4.6 Mar 05, 2020: DOJ files suit against spine device manufacturer and executives alleging kickbacks to surgeons through sham consulting payments 577
18.4.7 Feb 24, 2020: FDA grants Altair Medical’s RESPMETER breakthrough status to tackle opioid crisis 578
18.4.8 Feb 21, 2020: Philips and Intercept TeleMed spur new breed of tele-ICU for small Hospitals 578
18.4.9 Feb 14, 2020: SpineGuard initiates safeguard proceedings while adapting its governance to strengthen the development of innovation 580
18.5 Other Significant Developments 581
18.5.1 Jan 21, 2021: OrthogenRx announces 2020 achievements 581
18.5.2 Jan 06, 2021: Willamette Surgery Center celebrates record year of total joint replacements 582
18.5.3 Jan 06, 2021: SINTX Technologies looks ahead to 2021 opportunities and beyond 582
18.5.4 Dec 15, 2020: Future-proof your orthopaedic clinic with advanced orthopaedic imaging 583
18.5.5 Dec 09, 2020: Globus Medical trauma division awarded purchasing agreement with Premier 583
18.5.6 Dec 01, 2020: Zimmer Biomet Foundation launches, supporting diverse and underserved communities, STEM education, community health and disaster relief 583
18.5.7 Nov 20, 2020: TheraCell announces royalty milestone from licensing 584
18.5.8 Oct 22, 2020: joimax announces partnership with Southeast Asia distributor, Transmedic Group 584
18.5.9 Oct 14, 2020: NuVasive announces new organizational structure to align global commercial operations and product & services organization with long-term strategy 585
18.5.10 Oct 12, 2020: Ten facts on Osteoarthritis to commemorate World Arthritis Day 585
18.5.11 Oct 06, 2020: Tyber Medical launches clinical study for titanium integrated interbody devices 586
18.5.12 Oct 05, 2020: OPUM partners with leading US surgical electronic healthcare provider 587
18.5.13 Sep 16, 2020: Willamette Surgery Center now offering highly advanced robotic-arm assisted joint replacement procedures with Stryker’s mako system 587
18.5.14 Sep 10, 2020: Orthopedic Care partners announces affiliation with OrthoAspen 587
18.5.15 Aug 20, 2020: Conformis Announces achievement of second milestone under development and license agreements 588
18.5.16 Aug 18, 2020: MedShape receives $2.6M DOD development grant for novel NiTiNOL Dynamic Compression devices 588
18.5.17 Aug 13, 2020: Medline joins NPPGov as an approved vendor offering top-notch medical supplies 589
18.5.18 Aug 11, 2020: ICM Brain and Spine Institute selects Western Digital OpenFlex solution to speed up time to discovery of critical cures and treatment options 589
18.5.19 Aug 10, 2020: Navidea Biopharmaceuticals signs binding framework for commercialization partnership with Jubilant Radiopharma 591
18.5.20 Aug 03, 2020: Hyaluronic acid provides knee oa pain relief with lower costs, fewer adverse outcomes vs. corticosteroids or knee arthroplasty 592
18.5.21 Jul 28, 2020: Impressio and MedShape awarded competitive grant from the National Science Foundation to develop joint replacement device 592
18.5.22 Jul 13, 2020: Breg and UK/Ireland distributor Joint Operations announce new partnership 593
18.5.23 Jul 07, 2020: New collagen supply agreement with NovaBone Products 593
18.5.24 Jul 02, 2020: Osteopore signs initial U.S. distribution agreement 593
18.5.25 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education 594
18.5.26 May 28, 2020: Conformis announces settlement of patent dispute 594
18.5.27 May 19, 2020: Hackensack Meridian Health invests in EpiBone a regenerative medicine company 594
18.5.28 Apr 23, 2020: Lincotek Medical meets future challenges 595
18.5.29 Apr 20, 2020: Conformis receives $4.7 million under the Paycheck Protection Program 596
18.5.30 Apr 14, 2020: Biogennix remains operational as it prepares for Post-Coronavirus Surgical Demand 596
18.5.31 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19 596
18.5.32 Apr 02, 2020: SI-BONE provides business update in response to covid-19 pandemic 597
18.5.33 Mar 23, 2020: Conformis announces actions to mitigate COVID-19 impact 598
18.5.34 Mar 10, 2020: APLIX announces new inter-mold hooks for medical and orthopedic applications 599
18.5.35 Mar 06, 2020: Pentax Medical donates USD430,000 worth of medical devices to fight novel corona virus (2019-ncov) 600
18.5.36 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol 600
18.5.37 Feb 25, 2020: New study gets to the root of fixing pediatric flatfeet 601
18.5.38 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes 602
18.5.39 Feb 19, 2020: Novastep announces exclusive distribution and strategic alliance with Carbon22 602
18.5.40 Feb 18, 2020: Charlotte Radiology triples self-scheduled screening mammogram appointments in five months with convenient mobile option from SCI Solutions 603
18.5.41 Feb 12, 2020: Regenexx, first to use stem cells in orthopedic therapy, marks 15th anniversary 604
18.5.42 Feb 03, 2020: 3D Systems expands Sanmina relationship to provide plastic printer manufacturing — driving greater quality, availability, and reliability while improving 3d systems’ cost structure 605
18.5.43 Jan 31, 2020: Pitt’s Center for Medical Innovation awards three novel biomedical projects with $47,500 in Round 2 2019 Pilot Funding 605
18.5.44 Jan 27, 2020: Breg adds benefits and eligibility checks to Breg Vision software for orthopedic bracing programs 606
18.6 Product News 606
18.6.1 Jan 14, 2021: N2 Biomedical announces the first surgical implant of a spinal device coated with the company’s thin, ion-assisted titanium coating technology 606
18.6.2 Jan 08, 2021: New study helps forecast functional recovery time and return to activities following hip fracture Surgery 607
18.6.3 Dec 16, 2020: InventHelp inventor develops healthcare apparatus for spinal decompression (IPL-774) 607
18.6.4 Dec 15, 2020: HSS bone study sheds light on complications after spinal surgery 607
18.6.5 Nov 09, 2020: Rapid recovery protocol can lead to increased range of motion after total knee arthroplasty 608
18.6.6 Nov 04, 2020: WFIRM scientists create hybrid tissue construct for cartilage regeneration 609
18.6.7 Oct 20, 2020: Vaishali Pharma achieved major milestone by launching products in the U.S.A market 610
18.6.8 Oct 14, 2020: Researchers use lab-grown tissue grafts for personalized joint replacement 611
18.6.9 Oct 12, 2020: InventHelp inventor develops unique medical rehab device (OTW-613) 612
18.6.10 Oct 06, 2020: ATEC announces commercial release of distinct, comprehensive TLIF approach 612
18.6.11 Oct 05, 2020: Aurora Spine’s patent related to DEXA technology patient-matched implant technology issued by the United States Patent Office 613
18.6.12 Oct 05, 2020: ATEC announces novel PTP approach 613
18.6.13 Sep 08, 2020: BioPoly granted an international patent for its implant technology 614
18.6.14 Aug 26, 2020: Promimic’s business partner launches unique 3D-printed implants following FDA approval 614
18.6.15 Aug 20, 2020: Ekso Bionics unveils its latest assistive exoskeleton innovation for industrial use 615
18.6.16 Jul 13, 2020: InventHelp inventor develops back extender for applying tension to compressed vertebrae (AVZ-1893) 615
18.6.17 Jul 06, 2020: Lower back pain can improve after total hip replacement according to HSS study 615
18.6.18 Jun 18, 2020: Spinal Elements lunches platform to reduce spine surgery consequences 616
18.6.19 Jun 17, 2020: Spinal Elements introduces its MIS Ultra platform of products and procedures designed to minimize the unintended consequences of spine surgery 617
18.6.20 Jun 15, 2020: Study finds similar short-term outcomes after two common minimally invasive spine procedures 617
18.6.21 Jun 08, 2020: No difference in outcomes between anterior and posterior surgical approaches for outpatient total hip replacement 618
18.6.22 Jun 08, 2020: Researchers develop 3D-printable material that mimics biological tissues 619
18.6.23 Jun 02, 2020: Hanger announces findings of newly published study that reveals significant cost benefits associated with earlier prosthetic fitting post-amputation 619
18.6.24 May 18, 2020: Texas A&M Lab develops 3D-functional bone tissues 620
18.6.25 May 11, 2020: Recall of specific lots of various polyethylene implants by Zimmer Biomet due to potential presence of elevated endotoxin levels 621
18.6.26 May 07, 2020: Exactech and KenSci publish research on the impact of artificial intelligence to predict clinical outcomes after shoulder arthroplasty 621
18.6.27 May 01, 2020: InventHelp inventor develops enhanced Knee Implant (LGI-2830) 622
18.6.28 Apr 27, 2020: SpineGuard strengthens its IP with the grant of three new patents 622
18.7 Research And Development 622
18.7.1 Jan 21, 2021: Conformis and SITES Medical announce development & supply agreement 622
18.8 Strategy And Business Planning 623
18.8.1 Jan 15, 2021: OrthoPediatrics expands its agent network in three strategic European countries 623
18.8.2 Nov 05, 2020: 3D Systems, Veterans Health Administration collaboration transforms patient care for U.S. Veterans 623
18.8.3 Oct 21, 2020: Evonik sells stake in Synoste to Globus Medical in successful venture capital exit 624
18.8.4 Sep 22, 2020: Orthofix and Neo Medical announce partnership to develop and market single-use spinal solutions focused on improving patient outcomes 624
18.8.5 Sep 02, 2020: Campbell Clinic and Rendina celebrate grand opening of 120,000 SF MOB in Germantown, Tenn. 625
18.8.6 Aug 28, 2020: Wenzel Spine acquires spine imaging analytics firm Statera Spine 625
18.8.7 Aug 06, 2020: WishBone Medical acquires two firms to expand sterile spine product range 626
18.8.8 Aug 03, 2020: Exagen announces a collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome 626
18.8.9 Jul 27, 2020: Vizient awards contract to Wishbone Medical to deliver anatomically appropriate orthopedic implants & instruments to surgeons caring for children 627
18.8.10 Jun 26, 2020: Valet Health & DataBiologics combined solution support of data-driven physicians offering orthobiologics treatments 627
18.8.11 Jun 25, 2020: Integer Opens New Innovative Ireland Research and Development Facility 628
18.8.12 Jun 23, 2020: Graham Company and Regenexx announce innovative partnership to reduce orthopedic surgical spend for employers 628
18.8.13 Apr 08, 2020: HSS urgent ortho care opens in NYC, long Island, NJ and CT 629
18.8.14 Mar 03, 2020: OrthoPediatrics announces direct sales agency expansion in Italy 629
18.8.15 Mar 02, 2020: ATEC signs agreement to acquire EOS imaging 630
18.8.16 Feb 20, 2020: FORMA Therapeutics announces FT-4202 granted Fast Track Designation and Rare Pediatric Disease designation for treatment of sickle cell disease 630
18.8.17 Feb 20, 2020: Galderma announces New England Journal of Medicine publication from phase 2 study of investigational therapy Nemolizumab in patients with moderate to severe Prurigo Nodularis 631
18.8.18 Feb 20, 2020: Integer acquires Israel-based medical device firm Inomec 632
18.8.19 Feb 18, 2020: Georgia Bone & Joint Partners With AMP Recover To Service Self-Funded Employer Market 632
18.8.20 Feb 12, 2020: Sanford announces new Bemidji heart center 633
18.8.21 Jan 30, 2020: DeGen Medical expands operations to Charleston, South Carolina 633
18.8.22 Jan 27, 2020: Spine Care Technologies and Zober Industries announce Strategic Alliance 634
19 Appendix 635
19.1 Research Methodology 636
19.1.1 Coverage 636
19.1.2 Secondary Research 636
19.1.3 Primary Research 637
19.1.4 Market Modeling and Forecasting 638
19.1.5 Company Share Analysis 639
19.1.6 Distribution Share Analysis 640
19.1.7 Benchmarking 640
19.2 GlobalData Consulting 640
19.3 Contact Us 641
19.4 Disclaimer 641
Table
1.1 List of Tables
Table 1: Orthopedic Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 47
Table 2: Orthopedic Devices Market, United States, Category Contribution by Revenue ($m), 2019 50
Table 3: Orthopedic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2020 52
Table 4: Orthopedic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2021-2025 53
Table 5: Orthopedic Devices Market, United States, Volume (Units), 2015-2025 55
Table 6: Orthopedic Devices Market, United States, Volume (Units), Historic, 2015-2020 57
Table 7: Orthopedic Devices Market, United States, Volume (Units), Forecast, 2021-2025 58
Table 8: Orthopedic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2019 60
Table 9: Arthroscopy Market, United States, Segment Contribution (%), 2019 62
Table 10: Arthroscopy Market, United States, Revenue ($m), USD Constant, 2015-2020 64
Table 11: Arthroscopy Market, United States, Revenue ($m), USD Constant, 2021-2025 65
Table 12: Arthroscopes and Arthroscopic Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 67
Table 13: Arthroscopes and Arthroscopic Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 67
Table 14: Arthroscopic Shavers Market, United States, Revenue ($m), USD Constant, 2015-2020 69
Table 15: Arthroscopic Shavers Market, United States, Revenue ($m), USD Constant, 2021-2025 69
Table 16: Arthroscopy Implants Market, United States, Revenue ($m), USD Constant, 2015-2020 71
Table 17: Arthroscopy Implants Market, United States, Revenue ($m), USD Constant, 2021-2025 71
Table 18: Arthroscopy Radio Frequency Systems and Wands Market, United States, Revenue ($m), USD Constant, 2015-2020 73
Table 19: Arthroscopy Radio Frequency Systems and Wands Market, United States, Revenue ($m), USD Constant, 2021-2025 73
Table 20: Arthroscopy Market, United States, Volume (Units), 2015-2020 75
Table 21: Arthroscopy Market, United States, Volume (Units), 2021-2025 75
Table 22: Arthroscopes and Arthroscopic Systems Market, United States, Volume (Units), 2015-2020 77
Table 23: Arthroscopes and Arthroscopic Systems Market, United States, Volume (Units), 2021-2025 77
Table 24: Arthroscopic Shavers Market, United States, Volume (Units), 2015-2020 79
Table 25: Arthroscopic Shavers Market, United States, Volume (Units), 2021-2025 79
Table 26: Arthroscopy Implants Market, United States, Volume (Units), 2015-2020 81
Table 27: Arthroscopy Implants Market, United States, Volume (Units), 2021-2025 81
Table 28: Arthroscopy Radio Frequency Systems and Wands Market, United States, Volume (Units), 2015-2020 83
Table 29: Arthroscopy Radio Frequency Systems and Wands Market, United States, Volume (Units), 2021-2025 83
Table 30: Arthroscopy Market, United States, Average Price ($), 2015-2020 84
Table 31: Arthroscopy Market, United States, Average Price ($), 2021-2025 85
Table 32: Arthroscopy Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 86
Table 33: Arthroscopy Market, United States, Company Share by Revenue ($m), USD Constant, 2019 88
Table 34: Cranio Maxillofacial Fixation (CMF) Market, United States, Segment Contribution (%), 2019 90
Table 35: Cranio Maxillofacial Fixation (CMF) Market, United States, Revenue ($m), USD Constant, 2015-2020 92
Table 36: Cranio Maxillofacial Fixation (CMF) Market, United States, Revenue ($m), USD Constant, 2021-2025 92
Table 37: Distraction Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 94
Table 38: Distraction Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 94
Table 39: Plate and Screw Fixators Market, United States, Revenue ($m), USD Constant, 2015-2020 96
Table 40: Plate and Screw Fixators Market, United States, Revenue ($m), USD Constant, 2021-2025 96
Table 41: Cranio Maxillofacial Fixation (CMF) Market, United States, Volume (Units), 2015-2020 98
Table 42: Cranio Maxillofacial Fixation (CMF) Market, United States, Volume (Units), 2021-2025 98
Table 43: Distraction Systems Market, United States, Volume (Units), 2015-2020 100
Table 44: Distraction Systems Market, United States, Volume (Units), 2021-2025 100
Table 45: Plate and Screw Fixators Market, United States, Volume (Units), 2015-2020 102
Table 46: Plate and Screw Fixators Market, United States, Volume (Units), 2021-2025 102
Table 47: Cranio Maxillofacial Fixation (CMF) Market, United States, Average Price ($), 2015-2020 103
Table 48: Cranio Maxillofacial Fixation (CMF) Market, United States, Average Price ($), 2021-2025 103
Table 49: Cranio Maxillofacial Fixation (CMF) Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 104
Table 50: Cranio Maxillofacial Fixation (CMF) Market, United States, Company Share by Revenue ($m), USD Constant, 2019 106
Table 51: Hip Reconstruction Market, United States, Segment Contribution (%), 2019 108
Table 52: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2020 110
Table 53: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2021-2025 110
Table 54: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 112
Table 55: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 112
Table 56: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 114
Table 57: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 114
Table 58: Hip Reconstruction Market, United States, Volume (Units), 2015-2020 116
Table 59: Hip Reconstruction Market, United States, Volume (Units), 2021-2025 116
Table 60: Partial Hip Replacement Market, United States, Volume (Units), 2015-2020 118
Table 61: Partial Hip Replacement Market, United States, Volume (Units), 2021-2025 118
Table 62: Primary Hip Replacement Market, United States, Volume (Units), 2015-2020 120
Table 63: Primary Hip Replacement Market, United States, Volume (Units), 2021-2025 120
Table 64: Hip Reconstruction Market, United States, Average Price ($), 2015-2020 121
Table 65: Hip Reconstruction Market, United States, Average Price ($), 2021-2025 122
Table 66: Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 123
Table 67: Hip Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2019 125
Table 68: Knee Reconstruction Market, United States, Segment Contribution (%), 2019 127
Table 69: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2020 129
Table 70: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, 2021-2025 129
Table 71: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 131
Table 72: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 131
Table 73: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 133
Table 74: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 133
Table 75: Knee Reconstruction Market, United States, Volume (Units), 2015-2020 135
Table 76: Knee Reconstruction Market, United States, Volume (Units), 2021-2025 135
Table 77: Partial Knee Replacement Market, United States, Volume (Units), 2015-2020 137
Table 78: Partial Knee Replacement Market, United States, Volume (Units), 2021-2025 137
Table 79: Primary Knee Replacement Market, United States, Volume (Units), 2015-2020 139
Table 80: Primary Knee Replacement Market, United States, Volume (Units), 2021-2025 139
Table 81: Knee Reconstruction Market, United States, Average Price ($), 2015-2020 140
Table 82: Knee Reconstruction Market, United States, Average Price ($), 2021-2025 141
Table 83: Knee Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 142
Table 84: Knee Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2019 144
Table 85: Orthobiologics Market, United States, Segment Contribution (%), 2019 146
Table 86: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2015-2020 148
Table 87: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2021-2025 149
Table 88: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020 151
Table 89: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025 152
Table 90: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2015-2020 154
Table 91: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2021-2025 154
Table 92: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2015-2020 156
Table 93: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2021-2025 156
Table 94: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2015-2020 158
Table 95: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2021-2025 158
Table 96: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2015-2020 160
Table 97: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2021-2025 160
Table 98: Orthobiologics Market, United States, Volume (Units), 2015-2020 162
Table 99: Orthobiologics Market, United States, Volume (Units), 2021-2025 163
Table 100: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2020 165
Table 101: Bone Grafts and Substitutes Market, United States, Volume (Units), 2021-2025 166
Table 102: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2020 168
Table 103: Bone Growth Stimulators Market, United States, Volume (Units), 2021-2025 168
Table 104: Cartilage Repair Market, United States, Volume (Units), 2015-2020 170
Table 105: Cartilage Repair Market, United States, Volume (Units), 2021-2025 170
Table 106: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2020 172
Table 107: Soft Tissue Biologics Market, United States, Volume (Units), 2021-2025 172
Table 108: Viscosupplementation Market, United States, Volume (Units), 2015-2020 174
Table 109: Viscosupplementation Market, United States, Volume (Units), 2021-2025 174
Table 110: Orthobiologics Market, United States, Average Price ($), 2015-2020 175
Table 111: Orthobiologics Market, United States, Average Price ($), 2021-2025 177
Table 112: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 179
Table 113: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2019 181
Table 114: Orthopedic Bone Cement and Casting Materials Market, United States, Segment Contribution (%), 2019 183
Table 115: Orthopedic Bone Cement and Casting Materials Market, United States, Revenue ($m), USD Constant, 2015-2020 185
Table 116: Orthopedic Bone Cement and Casting Materials Market, United States, Revenue ($m), USD Constant, 2021-2025 185
Table 117: Bone Cement Market, United States, Revenue ($m), USD Constant, 2015-2020 187
Table 118: Bone Cement Market, United States, Revenue ($m), USD Constant, 2021-2025 187
Table 119: Casting Materials Market, United States, Revenue ($m), USD Constant, 2015-2020 189
Table 120: Casting Materials Market, United States, Revenue ($m), USD Constant, 2021-2025 189
Table 121: Orthopedic Bone Cement and Casting Materials Market, United States, Volume (Units), 2015-2020 191
Table 122: Orthopedic Bone Cement and Casting Materials Market, United States, Volume (Units), 2021-2025 191
Table 123: Bone Cement Market, United States, Volume (Units), 2015-2020 193
Table 124: Bone Cement Market, United States, Volume (Units), 2021-2025 193
Table 125: Casting Materials Market, United States, Volume (Units), 2015-2020 195
Table 126: Casting Materials Market, United States, Volume (Units), 2021-2025 195
Table 127: Orthopedic Bone Cement and Casting Materials Market, United States, Average Price ($), 2015-2020 196
Table 128: Orthopedic Bone Cement and Casting Materials Market, United States, Average Price ($), 2021-2025 196
Table 129: Orthopedic Bone Cement and Casting Materials Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 197
Table 130: Orthopedic Bone Cement and Casting Materials Market, United States, Company Share by Revenue ($m), USD Constant, 2019 199
Table 131: Orthopedic Power Tools and Consumables Market, United States, Segment Contribution (%), 2019 201
Table 132: Orthopedic Power Tools and Consumables Market, United States, Revenue ($m), USD Constant, 2015-2020 203
Table 133: Orthopedic Power Tools and Consumables Market, United States, Revenue ($m), USD Constant, 2021-2025 203
Table 134: Consumables Market, United States, Revenue ($m), USD Constant, 2015-2020 205
Table 135: Consumables Market, United States, Revenue ($m), USD Constant, 2021-2025 205
Table 136: Power Tools Market, United States, Revenue ($m), USD Constant, 2015-2020 207
Table 137: Power Tools Market, United States, Revenue ($m), USD Constant, 2021-2025 207
Table 138: Orthopedic Power Tools and Consumables Market, United States, Volume (Units), 2015-2020 209
Table 139: Orthopedic Power Tools and Consumables Market, United States, Volume (Units), 2021-2025 209
Table 140: Consumables Market, United States, Volume (Units), 2015-2020 211
Table 141: Consumables Market, United States, Volume (Units), 2021-2025 211
Table 142: Power Tools Market, United States, Volume (Units), 2015-2020 213
Table 143: Power Tools Market, United States, Volume (Units), 2021-2025 213
Table 144: Orthopedic Power Tools and Consumables Market, United States, Average Price ($), 2015-2020 214
Table 145: Orthopedic Power Tools and Consumables Market, United States, Average Price ($), 2021-2025 215
Table 146: Orthopedic Power Tools and Consumables Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 216
Table 147: Orthopedic Power Tools and Consumables Market, United States, Company Share by Revenue ($m), USD Constant, 2019 218
Table 148: Other Joint Reconstruction Market, United States, Segment Contribution (%), 2019 220
Table 149: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2020 222
Table 150: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2021-2025 223
Table 151: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 225
Table 152: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 225
Table 153: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 227
Table 154: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 227
Table 155: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 229
Table 156: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 229
Table 157: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 231
Table 158: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 231
Table 159: Other Joint Reconstruction Market, United States, Volume (Units), 2015-2020 233
Table 160: Other Joint Reconstruction Market, United States, Volume (Units), 2021-2025 234
Table 161: Ankle Replacement Market, United States, Volume (Units), 2015-2020 236
Table 162: Ankle Replacement Market, United States, Volume (Units), 2021-2025 236
Table 163: Digits Replacement Market, United States, Volume (Units), 2015-2020 238
Table 164: Digits Replacement Market, United States, Volume (Units), 2021-2025 238
Table 165: Elbow Replacement Market, United States, Volume (Units), 2015-2020 240
Table 166: Elbow Replacement Market, United States, Volume (Units), 2021-2025 240
Table 167: Wrist Replacement Market, United States, Volume (Units), 2015-2020 242
Table 168: Wrist Replacement Market, United States, Volume (Units), 2021-2025 242
Table 169: Other Joint Reconstruction Market, United States, Average Price ($), 2015-2020 243
Table 170: Other Joint Reconstruction Market, United States, Average Price ($), 2021-2025 244
Table 171: Other Joint Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 245
Table 172: Other Joint Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2019 247
Table 173: Shoulder Replacement Market, United States, Segment Contribution (%), 2019 249
Table 174: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 251
Table 175: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 252
Table 176: Shoulder Replacement Market, United States, Volume (Units), 2015-2020 254
Table 177: Shoulder Replacement Market, United States, Volume (Units), 2021-2025 255
Table 178: Shoulder Replacement Market, United States, Average Price ($), 2015-2020 256
Table 179: Shoulder Replacement Market, United States, Average Price ($), 2021-2025 256
Table 180: Shoulder Replacement Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 257
Table 181: Shoulder Replacement Market, United States, Company Share by Revenue ($m), USD Constant, 2019 259
Table 182: Spinal Surgery Market, United States, Segment Contribution (%), 2019 261
Table 183: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2015-2020 263
Table 184: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2021-2025 264
Table 185: Minimal Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 266
Table 186: Minimal Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 266
Table 187: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2015-2020 268
Table 188: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2021-2025 268
Table 189: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2015-2020 270
Table 190: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2021-2025 271
Table 191: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 273
Table 192: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 273
Table 193: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 275
Table 194: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 275
Table 195: Spinal Surgery Market, United States, Volume (Units), 2015-2020 277
Table 196: Spinal Surgery Market, United States, Volume (Units), 2021-2025 278
Table 197: Minimal Invasive Spinal Devices Market, United States, Volume (Units), 2015-2020 280
Table 198: Minimal Invasive Spinal Devices Market, United States, Volume (Units), 2021-2025 280
Table 199: Spinal Fusion Market, United States, Volume (Units), 2015-2020 282
Table 200: Spinal Fusion Market, United States, Volume (Units), 2021-2025 282
Table 201: Spinal Non-Fusion Market, United States, Volume (Units), 2015-2020 284
Table 202: Spinal Non-Fusion Market, United States, Volume (Units), 2021-2025 285
Table 203: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2015-2020 287
Table 204: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2021-2025 287
Table 205: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2015-2020 289
Table 206: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2021-2025 289
Table 207: Spinal Surgery Market, United States, Average Price ($), 2015-2020 290
Table 208: Spinal Surgery Market, United States, Average Price ($), 2021-2025 292
Table 209: Spinal Surgery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 294
Table 210: Spinal Surgery Market, United States, Company Share by Revenue ($m), USD Constant, 2019 296
Table 211: Trauma Fixation Market, United States, Segment Contribution (%), 2019 298
Table 212: Trauma Fixation Market, United States, Revenue ($m), USD Constant, 2015-2020 300
Table 213: Trauma Fixation Market, United States, Revenue ($m), USD Constant, 2021-2025 300
Table 214: External Fixators Market, United States, Revenue ($m), USD Constant, 2015-2020 302
Table 215: External Fixators Market, United States, Revenue ($m), USD Constant, 2021-2025 302
Table 216: Internal Fixators Market, United States, Revenue ($m), USD Constant, 2015-2020 304
Table 217: Internal Fixators Market, United States, Revenue ($m), USD Constant, 2021-2025 305
Table 218: Trauma Fixation Market, United States, Volume (Units), 2015-2020 307
Table 219: Trauma Fixation Market, United States, Volume (Units), 2021-2025 307
Table 220: External Fixators Market, United States, Volume (Units), 2015-2020 309
Table 221: External Fixators Market, United States, Volume (Units), 2021-2025 309
Table 222: Internal Fixators Market, United States, Volume (Units), 2015-2020 311
Table 223: Internal Fixators Market, United States, Volume (Units), 2021-2025 312
Table 224: Trauma Fixation Market, United States, Average Price ($), 2015-2020 313
Table 225: Trauma Fixation Market, United States, Average Price ($), 2021-2025 314
Table 226: Trauma Fixation Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 315
Table 227: Trauma Fixation Market, United States, Company Share by Revenue ($m), USD Constant, 2019 316
Table 228: Orthopedic Devices Market Pipeline Products 320
Table 229: DJO Acquires Trilliant Surgical 324
Table 230: ARCH Global Precision Acquires LISI Medical Jeropa 325
Table 231: STERIS to Acquire Cantel Medical 326
Table 232: Stryker Acquires OrthoSensor 328
Table 233: Curiteva Acquires FossiLabs 329
Table 234: Integra LifeSciences Acquires ACell 330
Table 235: Motion Dynamics Acquires ViaMed 332
Table 236: Pharmaron Acquires Absorption Systems 333
Table 237: Surgalign Holdings Acquires Holo Surgical 335
Table 238: WishBone Medical Acquires Back 2 Basics and Orbbo Surgical 337
Table 239: Vilex Acquires DT MedTech 338
Table 240: Spineart to Acquire Meditech Spine 339
Table 241: Nordson Acquires Fluortek 340
Table 242: Pantheon Spinal Acquires Incite Innovation 341
Table 243: Aspen Surgical Acquires Precept Medical Products 342
Table 244: Conventus Orthopaedics Acquires Flower Orthopedics 343
Table 245: Nextremity Solutions to Acquire Lakeland Technology 344
Table 246: Conatus Pharma Acquires Histogen 345
Table 247: Halma Acquires NovaBone Products 347
Table 248: Spinal Elements Acquires Assets of Benvenue Medical 348
Table 249: DJO Acquires STAR Ankle and Finger Arthroplasty Systems from Stryker 349
Table 250: Proteor USA to Acquire Freedom Innovations Assets from Ottobock 350
Table 251: Smith+Nephew Acquires Extremity Orthopaedics Business from Integra LifeSciences 351
Table 252: Pantheon Surgical Acquires Blue Topaz/CompresSIve Technology from Osseus Fusion Systems 353
Table 253: Steeper Acquires Espire Elbow Prostheses Range from College Park Industries 354
Table 254: Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023 355
Table 255: Baxter International to Raise USD650 Million in Private Placement of Notes Due 2031 356
Table 256: Johnson & Johnson Raises USD1 Billion in Public Offering of 0.550% Notes Due 2025 357
Table 257: Johnson & Johnson Raises USD1.5 Billion in Public Offering of 0.950% Notes Due 2027 359
Table 258: Johnson & Johnson Raises USD1.75 Billion in Public Offering of 1.300% Notes Due 2030 361
Table 259: Johnson & Johnson Raises USD1 Billion in Public Offering of 2.100% Notes Due 2040 363
Table 260: Johnson & Johnson Raises USD1 Billion in Public Offering of 2.250% Notes Due 2050 365
Table 261: Johnson & Johnson Raises USD1.25 Billion in Public Offering of 2.450% Notes Due 2060 367
Table 262: CryoLife Prices Private Placement of 4.250% Notes Due 2025 for USD100 Million 369
Table 263: NuVasive Raises USD450 Million in Private Placement of 1% Convertible Senior Notes Due 2023 371
Table 264: Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025 373
Table 265: Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030 375
Table 266: Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050 377
Table 267: Teleflex Prices Private Placement of 4.25% Notes Due 2028 for USD500 Million 379
Table 268: Cantel Medical Raises USD168 Million in Private Placement of 3.25% Notes Due 2025 380
Table 269: Nevro Announces Full Exercise of Underwriter’s Option to Purchase Additional 2.75% Notes Due 2025 for USD189.8 Million 382
Table 270: Baxter International Raises USD500 Million in Private Placement of 3.95% Senior Notes Due 2030 384
Table 271: Baxter International Raises USD750 Million in Private Placement of 3.75% Senior Notes Due 2025 385
Table 272: Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million 386
Table 273: Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million 388
Table 274: NuVasive Prices Private Placement of 0.375% Notes Due 2025 for USD450 Million 390
Table 275: Integra LifeSciences Prices Private Placement of 0.5% Convertible Senior Notes Due 2025 for USD500 Million 392
Table 276: Pro-Dex Plans to Raise up to USD25 million in Public Offering of Shares 394
Table 277: Histogen Raises USD14 Million in Public Offering of Shares 396
Table 278: PRO-Dex Plans to Raise up to USD100 Million in Public Offering 398
Table 279: Histogen Raises USD4.5 Million in Private Placement of Shares 400
Table 280: InVivo Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants 401
Table 281: SI-Bone Raises USD76.5 Million in Public Offering of Shares 403
Table 282: Alphatec Holdings Raises USD115 Million in Public Offering of Shares 405
Table 283: Spinal Elements to Raise up to USD115.5 Million in IPO of Shares 407
Table 284: Aziyo Biologics Prices IPO of Shares for USD50 Million 409
Table 285: SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities 410
Table 286: ConforMIS Prices Private Placement of Units for USD17.2 Million 411
Table 287: CryoLife Raises USD20 Million in Equity Financing 413
Table 288: Histogen Files Registration Statement for Public Offering of Securities for up to USD125 Million 414
Table 289: Ocugen Plans to Raise up to USD30 Million in Public Offering of Shares 415
Table 290: Xtant Medical to Raise up to USD15 Million in Rights Offering of Shares 417
Table 291: ConforMIS Plans to Raise up to USD25 Million in Public Offering of Shares 418
Table 292: SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares 419
Table 293: SINTX Technologies Prices Private Placement of Shares for USD3 Million 421
Table 294: ACell to Raise up to USD80 Million in IPO of Shares 422
Table 295: SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 424
Table 296: SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 426
Table 297: OrthoPediatrics Raises USD75.2 Million in Public Offering of Shares 427
Table 298: NFL Players Invests in TendoNova 429
Table 299: SurModics Plans to Raise up to USD200 Millon in Public Offering of Securities 430
Table 300: Hackensack Meridian Health Invests in EpiBone 431
Table 301: Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD75 Million 432
Table 302: Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD25 Million 434
Table 303: InVivo Therapeutics Raises USD3 Million in Private Placement of Shares 436
Table 304: Nevro Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares for USD157 Million 437
Table 305: Healios Invests Additional USD7 Million in Athersys 439
Table 306: Conformis Files Registration Statement for Public Offering of Securities up to USD200 Million 440
Table 307: InVivo Therapeutics Raises USD7 Million in Public Offering of Shares and Warrants 442
Table 308: CartiHeal May Raise up to USD80 Million in IPO of Shares 444
Table 309: DiscGenics to Raise Funds through Private Placement 445
Table 310: Myomo Raises USD15 Million in Public Offering of Shares 446
Table 311: Aurora Spine Raises USD0.2 Million in Equity Offering 448
Table 312: SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 449
Table 313: User-driven Retrospectively Supervised Classification Updating (RESCU) system for robust upper limb prosthesis control 450
Table 314: Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants 451
Table 315: Novel Test of Infant Hearing 452
Table 316: Performance Evaluation of a non-Degradable Synthetic Device for Chondral and Osteochondral Defects of the Knee 453
Table 317: Powered Hand Grip Orthosis for Functional Independence 454
Table 318: Multifunctional Semi-Powered Ankle Prosthesis: Phase II 455
Table 319: Noninvasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss 456
Table 320: Feasibility study of a nanostructural system for bone regeneration in preparation for dental implants 457
Table 321: Div. Supplement: Performance Evaluation of a non-Degradable Synthetic Device for Chondral and Osteochondral Defects of the Knee 458
Table 322: IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy 459
Table 323: User-driven Retrospectively Supervised Classification Updating (RESCU) system for robust upper limb prosthesis control 460
Table 324: Ultra-low Fouling and Nitric Oxide Releasing Intravascular Catheters for Prevention of Thrombosis and Infection 461
Table 325: Acumed Merges with OsteoMed 462
Table 326: Revive Therapeutics Enters into Research Collaboration with North Carolina State University 463
Table 327: Ortho Regenerative Enters into Licensing Agreement with Hanuman Pelican 464
Table 328: Center for Computational Imaging and Personalized Diagnostic (CCIPD) Enters into Research Agreement with Boehringer Ingelheim 465
Table 329: icotec Enters into Distribution Agreement with G21 466
Table 330: Exactech and Bodycad Enter into Distribution Agreement 467
Table 331: In2Bones USA and Invibio Enter into R&D, Development and Manufacturing Agreement 468
Table 332: QIAGEN Enters into Research License and Option Agreement with TScan Therapeutics to Develop T Cell-Based Lab Test for COVID-19 Immune Response 469
Table 333: Penumbra Enters into Partnership with RapidAI 470
Table 334: OPUM Enters into Agreement with iProcedures 471
Table 335: Orthofix Medical and Neo Medical Enter into Partnership 472
Table 336: Alphatec to Raise USD138 Million in Private Placement of Common Stock 473
Table 337: Umbra Companies to Acquire Ossifix Technologies 475
Table 338: LKCM Headwater Investments Invests USD20 Million in WishBone Medical 476
Table 339: Hyperice Raises Funds through Equity Financing 477
Table 340: ASP Navigate Acquires Life Sciences Unit from NN 479
Table 341: Histogen to Raise USD10 Million in Private Placement of Shares 481
Table 342: MiMedx to Raise USD100 Million in Private Equity Financing 483
Table 343: Fidelio Capital Acquires Majority Stake in Veterinary Orthopedic Implants 485
Table 344: HealthpointCapital Acquires Majority Stake in IlluminOss Medical 486
Table 345: York Special Opportunities Fund III Acquires Dr.’s Own (The Good Feet Store) 487
Table 346: Decathlon Capital Partners Invests in Cirtec Medical 488
Table 347: Lattice Biologics to Raise USD4.24 Million in Private Placement of Shares 489
Table 348: Fidelio Capital Acquires BioMedtrix 490
Table 349: Octave Bioscience Raises USD32 Million in Series B Financing 491
Table 350: Carlsmed Raises USD10 Million in Series A Financing 493
Table 351: Bio2 Technologies Raises USD3.2 Million in Venture Financing 494
Table 352: Curiteva Raises USD20 Million in Series A Funding Round 495
Table 353: CoNextions Medical Secures USD2.32 Million in Venture Funding 496
Table 354: Shoulder Innovations Raises USD21.6 Million in Venture Financing 497
Table 355: MBio Diagnostics (LightDeck Diagnostics) Raises USD11 Million in Series B Financing 499
Table 356: ReGelTec Raises USD3.75 Million in Venture Funding 500
Table 357: Cocoon Biotech Raises USD0.86 Million in Venture Financing 501
Table 358: Carmell Therapeutics Raises Additional USD2.3 Million in Venture Financing 502
Table 359: Parvizi Surgical Innovations Invests in Coracoid Solutions 503
Table 360: DiscGenics Raises USD4 Million in Series A Financing 504
Table 361: OrthAlign Raises USD11.2 Million in Venture Financing 505
Table 362: DiscGenics Raises USD50 Million in Series C Financing 506
Table 363: Active Life Scientific Raises USD1 Million in Venture Financing 508
Table 364: Paragon 28 Raises Funds through Series B Financing 509
Table 365: Ben Franklin Technology Partners Invests in Aevumed 510
Table 366: NuShores Biosciences Raises USD0.3 Million in Venture Financing 511
Table 367: CurvaFix Raises USD10.8 Million in Series B Financing 512
Table 368: Spine Align Raises USD1.7 Million in Seed Financing 513
Table 369: CurvaFix Raises USD3.08 Million in Venture Financing 514
Table 370: KAHTNU Surgical Raises USD2.2 Million in Series A Financing 515
Table 371: Ulcer Solutions to Raise USD0.65 Million in Venture Financing 516
Table 372: Carlsmed Raises USD2.5 Million in Seed Financing 517
Table 373: GRD Biomechanics Secures USD0.1 Million in Seed Funding 518
Table 374: HAPPE Spine Raises USD0.3 Million in Financing Round 519
Table 375: Solenic Medical Raises USD0.1 Million in Venture Financing 520
Table 376: Conventus Orthopaedics Raises USD24.5 Million in Venture Financing 521
Table 377: Onkos Surgical Raises USD7.6 Million in Venture Financing 522
Table 378: Precision Optics Raises USD0.3 Million in Venture Financing 523
Table 379: Centinel Spine Raises USD40.5 Million in Venture Financing 524
Table 380: Embody Raises USD9.2 Million in Series A Financing 525
Table 381: b-ONE Ortho Raises USD14 Million in Venture Financing 526
Table 382: Therapeutic Articulations Raises Funds through Venture Financing 528
Table 383: Vivorte Raises USD1 Million in Venture Financing 529
Table 384: Restor3d Raises Additional USD0.55 Million in Venture Financing 530
Table 385: TendoNova Raises Additional USD0.1 Million in Venture Financing 531
Table 386: Nanovis Raises USD5.4 Million in Venture Financing 532
Table 387: Apos Medical (Apos Therapy) Raises Additional USD11 Million in Series A Financing 533
Table 388: CyMedica Orthopedics Raises USD2 Million in Venture Financing 534
Table 389: Integrity Implants Raises USD0.8 Million in Venture Financing 535
Table 390: Therapeutic Articulations Raises Funds through Financing Round 536
Table 391: Shoulder Innovations Raises USD2.2 Million in Venture Financing 537
Table 392: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 638
Figures
1.2 List of Figures
Figure 1: Orthopedic Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 46
Figure 2: Orthopedic Devices Market, United States, Revenue Mix ($m), 2019 48
Figure 3: Orthopedic Devices Market, United States, Category Contribution (%), 2019 49
Figure 4: Orthopedic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2025 51
Figure 5: Orthopedic Devices Market, United States, Volume (Units), 2015-2025 54
Figure 6: Orthopedic Devices Market, United States, Volume (Units), Historic, 2015-2025 56
Figure 7: Orthopedic Devices Market, United States, Company Share (%) 2019 59
Figure 8: Arthroscopy Market, United States, Revenue Mix ($m), 2019 61
Figure 9: Arthroscopy Market, United States, Segment Contribution (%), 2019 62
Figure 10: Arthroscopy Market, United States, Revenue ($m), USD Constant, 2015-2025 63
Figure 11: Arthroscopes and Arthroscopic Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 66
Figure 12: Arthroscopic Shavers Market, United States, Revenue ($m), USD Constant, 2015-2025 68
Figure 13: Arthroscopy Implants Market, United States, Revenue ($m), USD Constant, 2015-2025 70
Figure 14: Arthroscopy Radio Frequency Systems and Wands Market, United States, Revenue ($m), USD Constant, 2015-2025 72
Figure 15: Arthroscopy Market, United States, Volume (Units), 2015-2025 74
Figure 16: Arthroscopes and Arthroscopic Systems Market, United States, Volume (Units), 2015-2025 76
Figure 17: Arthroscopic Shavers Market, United States, Volume (Units), 2015-2025 78
Figure 18: Arthroscopy Implants Market, United States, Volume (Units), 2015-2025 80
Figure 19: Arthroscopy Radio Frequency Systems and Wands Market, United States, Volume (Units), 2015-2025 82
Figure 20: Arthroscopy Market, United States, Company Share (%) 2019 87
Figure 21: Cranio Maxillofacial Fixation (CMF) Market, United States, Revenue Mix ($m), 2019 89
Figure 22: Cranio Maxillofacial Fixation (CMF) Market, United States, Segment Contribution (%), 2019 90
Figure 23: Cranio Maxillofacial Fixation (CMF) Market, United States, Revenue ($m), USD Constant, 2015-2025 91
Figure 24: Distraction Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 93
Figure 25: Plate and Screw Fixators Market, United States, Revenue ($m), USD Constant, 2015-2025 95
Figure 26: Cranio Maxillofacial Fixation (CMF) Market, United States, Volume (Units), 2015-2025 97
Figure 27: Distraction Systems Market, United States, Volume (Units), 2015-2025 99
Figure 28: Plate and Screw Fixators Market, United States, Volume (Units), 2015-2025 101
Figure 29: Cranio Maxillofacial Fixation (CMF) Market, United States, Company Share (%) 2019 105
Figure 30: Hip Reconstruction Market, United States, Revenue Mix ($m), 2019 107
Figure 31: Hip Reconstruction Market, United States, Segment Contribution (%), 2019 108
Figure 32: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2025 109
Figure 33: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 111
Figure 34: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 113
Figure 35: Hip Reconstruction Market, United States, Volume (Units), 2015-2025 115
Figure 36: Partial Hip Replacement Market, United States, Volume (Units), 2015-2025 117
Figure 37: Primary Hip Replacement Market, United States, Volume (Units), 2015-2025 119
Figure 38: Hip Reconstruction Market, United States, Company Share (%) 2019 124
Figure 39: Knee Reconstruction Market, United States, Revenue Mix ($m), 2019 126
Figure 40: Knee Reconstruction Market, United States, Segment Contribution (%), 2019 127
Figure 41: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2025 128
Figure 42: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 130
Figure 43: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 132
Figure 44: Knee Reconstruction Market, United States, Volume (Units), 2015-2025 134
Figure 45: Partial Knee Replacement Market, United States, Volume (Units), 2015-2025 136
Figure 46: Primary Knee Replacement Market, United States, Volume (Units), 2015-2025 138
Figure 47: Knee Reconstruction Market, United States, Company Share (%) 2019 143
Figure 48: Orthobiologics Market, United States, Revenue Mix ($m), 2019 145
Figure 49: Orthobiologics Market, United States, Segment Contribution (%), 2019 146
Figure 50: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2015-2025 147
Figure 51: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025 150
Figure 52: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2015-2025 153
Figure 53: Cartilage Repair Market, United States, Revenue ($m), USD Constant, 2015-2025 155
Figure 54: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2015-2025 157
Figure 55: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2015-2025 159
Figure 56: Orthobiologics Market, United States, Volume (Units), 2015-2025 161
Figure 57: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2025 164
Figure 58: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2025 167
Figure 59: Cartilage Repair Market, United States, Volume (Units), 2015-2025 169
Figure 60: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2025 171
Figure 61: Viscosupplementation Market, United States, Volume (Units), 2015-2025 173
Figure 62: Orthobiologics Market, United States, Company Share (%) 2019 180
Figure 63: Orthopedic Bone Cement and Casting Materials Market, United States, Revenue Mix ($m), 2019 182
Figure 64: Orthopedic Bone Cement and Casting Materials Market, United States, Segment Contribution (%), 2019 183
Figure 65: Orthopedic Bone Cement and Casting Materials Market, United States, Revenue ($m), USD Constant, 2015-2025 184
Figure 66: Bone Cement Market, United States, Revenue ($m), USD Constant, 2015-2025 186
Figure 67: Casting Materials Market, United States, Revenue ($m), USD Constant, 2015-2025 188
Figure 68: Orthopedic Bone Cement and Casting Materials Market, United States, Volume (Units), 2015-2025 190
Figure 69: Bone Cement Market, United States, Volume (Units), 2015-2025 192
Figure 70: Casting Materials Market, United States, Volume (Units), 2015-2025 194
Figure 71: Orthopedic Bone Cement and Casting Materials Market, United States, Company Share (%) 2019 198
Figure 72: Orthopedic Power Tools and Consumables Market, United States, Revenue Mix ($m), 2019 200
Figure 73: Orthopedic Power Tools and Consumables Market, United States, Segment Contribution (%), 2019 201
Figure 74: Orthopedic Power Tools and Consumables Market, United States, Revenue ($m), USD Constant, 2015-2025 202
Figure 75: Consumables Market, United States, Revenue ($m), USD Constant, 2015-2025 204
Figure 76: Power Tools Market, United States, Revenue ($m), USD Constant, 2015-2025 206
Figure 77: Orthopedic Power Tools and Consumables Market, United States, Volume (Units), 2015-2025 208
Figure 78: Consumables Market, United States, Volume (Units), 2015-2025 210
Figure 79: Power Tools Market, United States, Volume (Units), 2015-2025 212
Figure 80: Orthopedic Power Tools and Consumables Market, United States, Company Share (%) 2019 217
Figure 81: Other Joint Reconstruction Market, United States, Revenue Mix ($m), 2019 219
Figure 82: Other Joint Reconstruction Market, United States, Segment Contribution (%), 2019 220
Figure 83: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2025 221
Figure 84: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 224
Figure 85: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 226
Figure 86: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 228
Figure 87: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 230
Figure 88: Other Joint Reconstruction Market, United States, Volume (Units), 2015-2025 232
Figure 89: Ankle Replacement Market, United States, Volume (Units), 2015-2025 235
Figure 90: Digits Replacement Market, United States, Volume (Units), 2015-2025 237
Figure 91: Elbow Replacement Market, United States, Volume (Units), 2015-2025 239
Figure 92: Wrist Replacement Market, United States, Volume (Units), 2015-2025 241
Figure 93: Other Joint Reconstruction Market, United States, Company Share (%) 2019 246
Figure 94: Shoulder Replacement Market, United States, Revenue Mix ($m), 2019 248
Figure 95: Shoulder Replacement Market, United States, Segment Contribution (%), 2019 249
Figure 96: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 250
Figure 97: Shoulder Replacement Market, United States, Volume (Units), 2015-2025 253
Figure 98: Shoulder Replacement Market, United States, Company Share (%) 2019 258
Figure 99: Spinal Surgery Market, United States, Revenue Mix ($m), 2019 260
Figure 100: Spinal Surgery Market, United States, Segment Contribution (%), 2019 261
Figure 101: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2015-2025 262
Figure 102: Minimal Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 265
Figure 103: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2015-2025 267
Figure 104: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2015-2025 269
Figure 105: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 272
Figure 106: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 274
Figure 107: Spinal Surgery Market, United States, Volume (Units), 2015-2025 276
Figure 108: Minimal Invasive Spinal Devices Market, United States, Volume (Units), 2015-2025 279
Figure 109: Spinal Fusion Market, United States, Volume (Units), 2015-2025 281
Figure 110: Spinal Non-Fusion Market, United States, Volume (Units), 2015-2025 283
Figure 111: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2015-2025 286
Figure 112: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2015-2025 288
Figure 113: Spinal Surgery Market, United States, Company Share (%) 2019 295
Figure 114: Trauma Fixation Market, United States, Revenue Mix ($m), 2019 297
Figure 115: Trauma Fixation Market, United States, Segment Contribution (%), 2019 298
Figure 116: Trauma Fixation Market, United States, Revenue ($m), USD Constant, 2015-2025 299
Figure 117: External Fixators Market, United States, Revenue ($m), USD Constant, 2015-2025 301
Figure 118: Internal Fixators Market, United States, Revenue ($m), USD Constant, 2015-2025 303
Figure 119: Trauma Fixation Market, United States, Volume (Units), 2015-2025 306
Figure 120: External Fixators Market, United States, Volume (Units), 2015-2025 308
Figure 121: Internal Fixators Market, United States, Volume (Units), 2015-2025 310
Figure 122: Trauma Fixation Market, United States, Company Share (%) 2019 316
Frequently asked questions
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab ABYour daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal FoodsHaving used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard CharteredOur experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYSGlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.
Related reports
View more Orthopedic Devices reportsEvery Company Report we produce is powered by the GlobalData Intelligence Center.
Subscribing to our intelligence platform means you can monitor developments at United States (USA) Orthopedic Devices Market Size (Value, Volume, ASP) by Segments (Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction and Others), Share and Forecast, 2015-2025 in real time.
- Access a live United States (USA) Orthopedic Devices Market Size (Value, Volume, ASP) by Segments (Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction and Others), Share and Forecast, 2015-2025 dashboard for 12 months, with up-to-the-minute insights.
- Fuel your decision making with real-time deal coverage and media activity.
- Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.